ES
Eric Schmidt Cantor Fitzgerald Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Legend Biotech
LEGN
$6.57B
| $35.60 | $66 |
85%
upside
| Overweight | 7 days ago |
|
2 |
2
Avidity Biosciences
RNA
$5.99B
| $46.54 | $96 |
106%
upside
| Overweight | 2 months ago |
|
3 |
BCAX
3
Bicara Therapeutics Inc. Common Stock
BCAX
$654M
| $11.99 | $13.01 |
9%
upside
| Overweight | 5 months ago |
|
4 |
4
Biogen
BIIB
$21.1B
| $144 | $292 |
103%
upside
| Overweight | 11 months ago |
|
5 |
5
Vertex Pharmaceuticals
VRTX
$103B
| $401.57 | $370 |
8%
downside
| Overweight | 1 year ago |
|